Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing 10 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 25 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 1 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 5 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 1 million cells
Bone Marrow CD34+ Cells, 100,000 cells, cryopreserved, positively selected
- 
	TechSheet - Poietics™ CD14+ MonocytesTechnical Use and Product Information
 - 
	Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
 - 
	Terms and ConditionsCD34+ cells BOGO
 - 
	TechSheet - Mouse Astrocyte Cell SystemsTechnical tips for culturing C57&CD1 Mouse Mixed Astrocytes
 - 
	Normal Peripheral Blood CD4+ T LymphocytesLonza Application Notes
 - 
	Webinar – Efficient Transfection of Biologically Relevant Cells in Immunology Research (pdf)Lonza_Webinars_Webinar__Efficient_Transfection_of_Biologically_Relevant_Cells_in_Immunology_Research.pdf
 - 
	
					    		
				    			
								
								Mitosis of CD34+ cells with Nanolive's 3D Cell ExplorerHuman cord blood CD34+ stem/progenitor cells were cultured in X-VIVO™ 15 serum-free hematopoietic cell medium, supplemented with recombinant human thrombopoietin (25ng/mL), Rlt3 ligand (25ng/mL) and stem cell factor (13ng/mL). The culture was coated with fibronectin. Live cell imaging was performed with Nanolive’s 3D Cell Explorer for 15 hours (3 images/min during 15hours) and cell division was captured. One can distinguish characteristic steps of mitosis affirming that Nanolive’s technology was completely non-invasive. - 
	CD34+ Cells for Cell and Gene Therapy Process DevelopmentIn this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
 - 
	Human CD34+ Cells Technical information and instructions for use
 - 
	Instructions - Mouse Astrocyte Cell SystemsInstructions for proper use and culture of C57 & CD1 Mouse Mixed Astrocytes